Nick Pavlakis

机构：The University of Sydney, Royal North Shore Hospital · ORCID：0000-0002-1738-0316

发表论文 572 篇 · 总被引 16759 次 · h-index 63

代表论文

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial (2025 · Journal of Clinical Oncology · 被引 28)
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 20)
Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer (2025 · Journal of Thoracic Oncology · 被引 8)
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia (2025 · Pathology · 被引 8)
[ 18 F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study (2025 · Journal of Nuclear Medicine · 被引 3)
Recommendations for molecular testing of lung cancer in Australia: consensus guidelines from the Royal College of Pathologists of Australasia and the Thoracic Oncology Group of Australasia (2025 · Pathology · 被引 2)